LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

ResMed Inc

Fermé

SecteurSoins de santé

258.83 1.53

Résumé

Variation du prix de l'action

24h

Actuel

Min

255.02

Max

262.01

Chiffres clés

By Trading Economics

Revenu

44M

393M

Ventes

87M

1.4B

P/E

Moyenne du Secteur

25.005

110.024

Rendement du dividende

0.92

Marge bénéficiaire

27.593

Employés

10,600

EBITDA

63M

566M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+19.04% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.92%

2.26%

Prochains Résultats

22 avr. 2026

Date du Prochain Dividende

19 mars 2026

Date du Prochain Détachement de Dividende

7 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-426M

37B

Ouverture précédente

257.3

Clôture précédente

258.83

Sentiment de l'Actualité

By Acuity

23%

77%

54 / 351 Classement par Healthcare

ResMed Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 févr. 2026, 22:31 UTC

Résultats

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 févr. 2026, 22:18 UTC

Résultats

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 févr. 2026, 22:11 UTC

Résultats

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 févr. 2026, 21:52 UTC

Résultats

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 févr. 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 févr. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 févr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 févr. 2026, 23:34 UTC

Market Talk
Résultats

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 févr. 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 févr. 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 févr. 2026, 22:45 UTC

Résultats

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 févr. 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 févr. 2026, 22:37 UTC

Résultats

Nutrien 4Q EPS $1.18 >NTR.T

18 févr. 2026, 22:37 UTC

Résultats

Nutrien 4Q Sales $5.34B >NTR.T

18 févr. 2026, 22:35 UTC

Résultats

Pan American Silver 4Q EPS $1.07 >PAAS

18 févr. 2026, 22:35 UTC

Résultats

Pan American Silver 4Q Rev $1.18B >PAAS

18 févr. 2026, 22:30 UTC

Résultats

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 févr. 2026, 22:29 UTC

Résultats

Kinross Gold 4Q EPS 75c >K.T

18 févr. 2026, 22:22 UTC

Résultats

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 févr. 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 févr. 2026, 22:16 UTC

Résultats

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 févr. 2026, 22:05 UTC

Résultats

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 févr. 2026, 22:03 UTC

Résultats

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q Sales $929M >KALU

18 févr. 2026, 22:02 UTC

Résultats

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 févr. 2026, 22:00 UTC

Résultats

Kinross Gold 4Q Adj EPS 67c >KGC

18 févr. 2026, 22:00 UTC

Résultats

Kinross Gold 4Q Sales $2.02B >KGC

18 févr. 2026, 21:56 UTC

Résultats

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 févr. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Comparaison

Variation de prix

ResMed Inc prévision

Objectif de Prix

By TipRanks

19.04% hausse

Prévisions sur 12 Mois

Moyen 300.64 USD  19.04%

Haut 345 USD

Bas 265 USD

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

13 ratings

8

Achat

5

Maintien

0

Vente

Sentiment

By Acuity

54 / 351Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat